FORMYL VORTIOXETINE (25 mg) (4-[2-(2,4-Dimethylphenylthio)phenyl]piperazine-1-carbaldehyde )

In Stock

Ready to ship

Catalogue No.

1A12530

CAS No.

2135576-73-5

Molecular Formula

C₁₉H₂₂N₂OS

Product Type

Pharmaceutical Analytical Impurities

$450.00

Shipping information

Click Here to learn more about Pharmaceutical Analytical Impurities (PAI). PAI products are different from official USP Reference Standards. This material is an Analytical Material and not a USP Reference Standard.

Additional information

Additional information

Current Lot Information

Current Lot:

F265B0

CAS RN®

2135576-73-5

Harmonized System (HS) Code *:

29335990

UN No:

N/A

NDC No:

N/A

Molecular Formula

C₁₉H₂₂N₂OS

Container Type:

VIAL

Base Control Substance (substance %):

N | A

Product Information

SDS:

USP Certificates/Product Information Sheets and Valid Use Dates

Lot No	USP Certificates/Product Information Sheets and Valid Use Dates	Valid Use Date	Country of Origin*	Material Origin*
F265B0	1A12530-F265B0	See Product Information Sheet	India	Chemical Synthesis


Lot No F265B0	USP Certificates/Product Information Sheets and Valid Use Dates 1A12530-F265B0
Valid Use Date See Product Information Sheet
Country of Origin* India
Material Origin* Chemical Synthesis

Lot No

F265B0

USP Certificates/Product Information Sheets and Valid Use Dates

1A12530-F265B0

Valid Use Date

See Product Information Sheet

Country of Origin*

India

Material Origin*

Chemical Synthesis

Frequently bought together

FORMYL VORTIOXETINE (25 mg) (4-[2-(2,4-Dimethylphenylthio)phenyl]piperazine-1-carbaldehyde )

Catalogue No.

1A12530

CAS No.

2135576-73-5

Molecular Formula

C₁₉H₂₂N₂OS

Product Type

Pharmaceutical Analytical Impurities

$450.00

RIZATRIPTAN N-METHYL ADDUCT IODIDE (25 mg) (2-{5-[(1H-1,2,4-Triazol-1-yl)methyl]-1H-indol-3-yl}-N,N,N-trimethylethan-1-aminium iodide)

Catalogue No.

1A10050

CAS No.

Molecular Formula

C₁₆H₂₂IN₅

Product Type

Pharmaceutical Analytical Impurities

$690.00

17α-HYDROXYPROGESTERONE (25 mg) (17-Hydroxypregn-4-ene-3,20-dione)

Catalogue No.

1A10140

CAS No.

68-96-2

Molecular Formula

C₂₁H₃₀O₃

Product Type

Pharmaceutical Analytical Impurities

$850.00

FORMYL VORTIOXETINE (25 mg) (4-[2-(2,4-Dimethylphenylthio)phenyl]piperazine-1-carbaldehyde )

CORTIENIC ACID (25 mg) ((11β,17α)-11,17-Dihydroxy-3-oxoandrost-4-ene-17-carboxylic acid)

6ß-HYDROXYHYDROCORTISONE (25 mg) (6β,11β,17,21-Tetrahydroxypregn-4-ene-3,20-dione)

PAZOPANIB 2-CHLOROPYRIMIDINE (25 mg) (N-(2-Chloropyrimidin-4-yl)-N,2,3-trimethyl-2H-indazol-6-amine)

DIHYDRO BECLOMETHASONE DIPROPIONATE (25 mg) (9-Chloro-11β-hydroxy-16β-methyl-3,20-dioxopregn-4-ene-17,21-diyl dipropionate )

TAZAROTENE THIOCHROMANE DIMER (25 mg) (1,4-bis(4,4-dimethylthiochroman-6-yl)buta-1,3-diyne )

PREDNISOLONE DIACETATE (25 mg) (17-Hydroxy-3,20-dioxopregna-1,4-diene-11β,21-diyl diacetate)

TETRAIODOTHYROACETIC ACID (25 mg) (2-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)acetic acid)

BROMO PIRFENIDONE (25 mg) (1-(4-Bromophenyl)-5-methylpyridin-2(1H)-one)

CLINDAMYCIN PALMITATE HYDROCHLORIDE SULFOXIDE (25 mg) (7-Chloro-1,6,7,8-tetradeoxy-6-[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido]-1-methylsulfinyl-L-threo-α-D-galacto-octopyranose 2-palmitate hydrochloride)